Skip to content

To compare the effect of Nimba taila Nasya and Bhrungaraja tail Nasya in dandruff (darunaka).

Randomized clinical trial to compare the efficacy of Nimba Tail and Bhrungaraja Tail Nasya in Darunaka (Dandruff).

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051148
Enrollment
100
Registered
2023-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L219- Seborrheic dermatitis, unspecified

Interventions

None listed

Sponsors

pournima Daware
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) patient with moderate adherent dandruff of the scalp. 2) Patients with chronicity of disease affecting from 3 months and more. 3) Patients Arha for Nasya karma.

Exclusion criteria

Exclusion criteria: 1.Scalp psoriasis, scalp eczema, other kapalgata vyadhi. 2. Patients having history of skin diseases, atopic dermatitis, and on oral medications e.g. systemic antifungal, systemic steroids, systemic antibiotics, systemic anti-inflammatory agents or topical steroids, topical anti-inflammatory agents, topical antibiotics or topical treatment of adherent dandruff (e.g. antidandruff shampoos/oils/gels/creams/ conditioners). 3. Patient suffering Autoimmune disorders like SLE, immunological deficiencies, Uncontrolled metabolic disorders like D.M, pregnant woman.

Design outcomes

Primary

MeasureTime frame
Changes in the clinical features like itching, dryness scaling etc of Dandruff is assessed with Adherent scalp flaking score of Dandruff .Timepoint: At baseline and after treatment 8th day

Secondary

MeasureTime frame
To study adverse effects if anyTimepoint: 7 day treatment follow-up on 8th, 15th day

Countries

India

Contacts

Public ContactPournima Daware

Graduate Studies and Research in Ayurveda

ayurvedapune@gmail.com9823050402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026